MOR Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$672K Buy
4,160
+451
+12% +$75.2K 0.25% 59
2026
Q2
$703K Sell
3,709
-493
-12% -$92.7K 0.28% 48
2026
Q1
$829K Buy
4,202
+1,338
+47% +$258K 0.38% 37
2025
Q4
$526K Buy
+2,864
New +$502K 0.24% 55

Other funds holding AZN

MOR Wealth Management's AZN Position: Q3 2026 in Review

MOR Wealth Management increased its AstraZeneca (AZN) stake by 12% in Q3 2026, buying an estimated $75.2K and bringing the position to 4,160 shares worth $672K. The position accounts for 0.25% of the portfolio, ranked #59.

MOR Wealth Management first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $829K in Q1 2026. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • MOR Wealth Management held 4,160 shares of AstraZeneca worth $672K as of Q3 2026.
  • MOR Wealth Management bought 451 AstraZeneca shares in Q3 2026, an estimated $75.2K.
  • AstraZeneca made up 0.25% of MOR Wealth Management's portfolio in Q3 2026, its #59 holding.
  • MOR Wealth Management first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • MOR Wealth Management's AstraZeneca position peaked at $829K in Q1 2026.
  • 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.